IL-12 family cytokines: immunological playmakers

Nature Immunology

Volumn 13, Issue 8, 2012, Pages 722-728

  Vignali, Dario A A ^a   Kuchroo, Vijay K ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 27; INTERLEUKIN 35; INTERLEUKIN 4; INTERLEUKIN 6; STAT PROTEIN;

ALPHA CHAIN; B LYMPHOCYTE; BETA CHAIN; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELL; G1 PHASE CELL CYCLE CHECKPOINT; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL;

HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKINS; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84864124859     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2366     Document Type: Review

References (97)

1. Collison, L.W. & Vignali, D.A. Interleukin-35:: odd one out or part of the family? Immunol. Rev. 226, 248-262 (2008).
2. Jones, L.L. & Vignali, D.A. Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily. Immunol. Res. 51, 5-14 (2011).
3. Hunter, C.A. New il-12-family members:: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5, 521-531 (2005). (Pubitemid 40961330)
4. Kastelein, R.A., Hunter, C.A. & Cua, D.J. Discovery and biology of IL-23 and IL-27:: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25, 221-242 (2007). (Pubitemid 46697908)
5. Langrish, C.L. et al. IL-12 and IL-23:: master regulators of innate and adaptive immunity. Immunol. Rev. 202, 96-105 (2004). (Pubitemid 39576907)
6. Cox, J.H. et al. IL-27 promotes T cell-dependent colitis through multiple mechanisms. J. Exp. Med. 208, 115-123 (2011).
7. Wojno, E.D. & Hunter, C.A. New directions in the basic and translational biology of interleukin-27. Trends Immunol. 33, 91-97 (2012).
8. Stumhofer, J.S. & Hunter, C.A. Advances in understanding the anti-inflammatory properties of IL-27. Immunol. Lett. 117, 123-130 (2008).
9. Pot, C., Apetoh, L., Awasthi, A. & Kuchroo, V.K. Induction of regulatory Tr1 cells and inhibition of TH17 cells by IL-27. Semin. Immunol. 23, 438-445 (2011).
10. Vignali, D.A.A., Collison, L.W. & Workman, C.J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523-532 (2008).
11. Wills-Karp, M. IL-12/IL-13 axis in allergic asthma. J. Allergy Clin. Immunol. 107, 9-18 (2001). (Pubitemid 32105236)
12. Martin-Orozco, N. & Dong, C. The IL-17/IL-23 axis of inflammation in cancer:: friend or foe? Curr. Opin. Investig. Drugs 10, 543-549 (2009).
13. Maloy, K.J. & Kullberg, M.C. IL-23 and Th17 cytokines in intestinal homeostasis. Mucosal Immunol. 1, 339-349 (2008).
14. Dong, C. IL-23/IL-17 biology and therapeutic considerations. J. Immunotoxicol. 5, 43-46 (2008). (Pubitemid 351431258)
15. McGeachy, M.J. & Cua, D.J. The link between IL-23 and Th17 cell-mediated immune pathologies. Semin. Immunol. 19, 372-376 (2007). (Pubitemid 351274049)
16. Kreymborg, K., Bohlmann, U. & Becher, B. IL-23:: changing the verdict on IL-12 function in inflammation and autoimmunity. Expert Opin. Ther. Targets 9, 1123-1136 (2005). (Pubitemid 41762868)
17. Crabé, S. et al. The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling. J. Immunol. 183, 7692-7702 (2009).
18. Kass, D.J. Cytokine-like factor 1 (CLF1):: life after development? Cytokine 55, 325-329 (2011).
19. Lupardus, P.J. & Garcia, K.C. The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12. J. Mol. Biol. 382, 931-941 (2008).
20. Beyer, B.M. et al. Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody. J. Mol. Biol. 382, 942-955 (2008).
21. Yoon, C. et al. Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12. EMBO J. 19, 3530-3541 (2000). (Pubitemid 30462112)
22. Jones, L.L., Chaturvedi, V., Uyttenhove, C., Van, S.J. & Vignali, D.A. Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family. Mol. Immunol. 51, 234-244 (2012).
23. Stumhofer, J.S. et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat. Immunol. 11, 1119-1126 (2010).
24. Cooper, A.M. & Khader, S.A. IL-12p40:: an inherently agonistic cytokine. Trends Immunol. 28, 33-38 (2007).
25. Khader, S.A. et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 203, 1805-1815 (2006). (Pubitemid 44036285)
26. Gately, M.K. et al. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann. NY Acad. Sci. 795, 1-12 (1996). (Pubitemid 27029550)
27. Gillessen, S. et al. Mouse interleukin-12 (IL-12) p40 homodimer:: a potent IL-12 antagonist. Eur. J. Immunol. 25, 200-206 (1995).
28. Delgoffe, G.M., Murray, P.J. & Vignali, D.A. Interpreting mixed signals:: the cell's cytokine conundrum. Curr. Opin. Immunol. 23, 632-638 (2011).
29. Collison, L.W. et al. The composition and signaling of the IL-35 receptor are unconventional. Nat. Immunol. 13, 290-299 (2012).
30. Wang, X., Lupardus, P., Laporte, S.L. & Garcia, K.C. Structural biology of shared cytokine receptors. Annu. Rev. Immunol. 27, 29-60 (2009).
31. Boulanger, M.J. et al. Molecular mechanisms for viral mimicry of a human cytokine:: activation of gp130 by HHV-8 interleukin-6. J. Mol. Biol. 335, 641-654 (2004). (Pubitemid 37532663)
32. Boulanger, M.J., Chow, D.C., Brevnova, E.E. & Garcia, K.C. Hexameric structure and assembly of the interleukin-6/IL-6 α-receptor/gp130 complex. Science 300, 2101-2104 (2003). (Pubitemid 36760138)
33. Szabo, S.J., Jacobson, N.G., Dighe, A.S., Gubler, U. & Murphy, K.M. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2, 665-675 (1995).
34. Szabo, S.J., Dighe, A.S., Gubler, U. & Murphy, K.M. Regulation of the interleukin (IL)-12Rβ2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185, 817-824 (1997). (Pubitemid 27119865)
35. Rogge, L. et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185, 825-831 (1997). (Pubitemid 27119866)
36. Ma, X. & Trinchieri, G. Regulation of interleukin-12 production in antigen-presenting cells. Adv. Immunol. 79, 55-92 (2001). (Pubitemid 32977574)
37. Yamanouchi, J. et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39, 329-337 (2007). (Pubitemid 46328484)
38. Villarino, A.V. et al. Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. J. Exp. Med. 204, 65-71 (2007). (Pubitemid 46148757)
39. Bancroft, A.J., Humphreys, N.E., Worthington, J.J., Yoshida, H. & Grencis, R.K. WSX-1:: a key role in induction of chronic intestinal nematode infection. J. Immunol. 172, 7635-7641 (2004). (Pubitemid 38747628)
40. Villarino, A.V. et al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J. Immunol. 174, 7684-7691 (2005). (Pubitemid 40806273)
41. + T cells. Immunity 16, 779-790 (2002). (Pubitemid 34786477)
42. Stumhofer, J.S. et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363-1371 (2007). (Pubitemid 350131173)
43. Fitzgerald, D.C. et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8, 1372-1379 (2007). (Pubitemid 350131174)
44. Awasthi, A. et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8, 1380-1389 (2007). (Pubitemid 350131175)
45. Pot, C. et al. Cutting edge:: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183, 797-801 (2009).
46. Diveu, C. et al. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol. 182, 5748-5756 (2009).
47. Apetoh, L. et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854-861 (2010).
48. Murugaiyan, G., Mittal, A. & Weiner, H.L. Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation. Proc. Natl. Acad. Sci. USA 107, 11495-11500 (2010).
49. + regulatory T cells. Nat. Immunol. 11, 846-853 (2010).
50. Presky, D.H. et al. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 93, 14002-14007 (1996).
51. Collison, L.W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569 (2007). (Pubitemid 350190247)
52. Collison, L.W., Pillai, M.R., Chaturvedi, V. & Vignali, D.A. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35-and IL-10-dependent manner. J. Immunol. 182, 6121-6128 (2009).
53. Collison, L.W. et al. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093-1101 (2010).
54. Petermann, F. et al. γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33, 351-363 (2010).
55. Fontenot, J.D., Rasmussen, J.P., Gavin, M.A. & Rudensky, A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151 (2005). (Pubitemid 41541792)
56. + regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6, 1152-1159 (2005). (Pubitemid 41541793)
57. Villarino, A.V. et al. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 176, 237-247 (2006). (Pubitemid 43023268)
58. Dickensheets, H.L., Freeman, S.L. & Donnelly, R.P. Interleukin-12 differentially regulates expression of IFN-γ and interleukin-2 in human T lymphoblasts. J. Interferon Cytokine Res. 20, 897-905 (2000).
59. Wojno, E.D. et al. A role for IL-27 in limiting T regulatory cell populations. J. Immunol. 187, 266-273 (2011).
60. Niedbala, W. et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 37, 3021-3029 (2007). (Pubitemid 350131282)
61. + Treg Cells. J. Biol. Regul. Homeost. Agents 24, 131-135 (2010).
62. Batten, M. et al. Cutting edge:: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 180, 2752-2756 (2008).
63. Chaturvedi, V., Collison, L.W., Guy, C.S., Workman, C.J. & Vignali, D.A. Cutting edge:: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J. Immunol. 186, 6661-6666 (2011).
64. Maldonado, R.A. et al. Control of T helper cell differentiation through cytokine receptor inclusion in the immunological synapse. J. Exp. Med. 206, 877-892 (2009).
65. Maldonado, R.A., Irvine, D.J., Schreiber, R. & Glimcher, L.H. A role for the immunological synapse in lineage commitment of CD4 lymphocytes. Nature 431, 527-532 (2004). (Pubitemid 39336325)
66. Canda-Sánchez, A. et al. Differential distribution of both IL-12Rβ chains in the plasma membrane of human T cells. J. Membr. Biol. 227, 1-12 (2009).
67. Ihle, J.N. STATs:: signal transducers and activators of transcription. Cell 84, 331-334 (1996). (Pubitemid 26058558)
68. Decker, T. & Kovarik, P. Serine phosphorylation of STATs. Oncogene 19, 2628-2637 (2000). (Pubitemid 30339219)
69. Decker, T. & Kovarik, P. Transcription factor activity of STAT proteins:: structural requirements and regulation by phosphorylation and interacting proteins. Cell Mol. Life Sci. 55, 1535-1546 (1999). (Pubitemid 29445819)
70. Ho, H.H. & Ivashkiv, L.B. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J. Biol. Chem. 281, 14111-14118 (2006). (Pubitemid 43848338)
71. Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct froMiL-12. Immunity 13, 715-725 (2000).
72. Kobayashi, M. et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845 (1989). (Pubitemid 19226667)
73. Chua, A.O. et al. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol. 153, 128-136 (1994). (Pubitemid 24186525)
74. Chua, A.O., Wilkinson, V.L., Presky, D.H. & Gubler, U. Cloning and characterization of a mouse IL-12 receptor-β component. J. Immunol. 155, 4286-4294 (1995).
75. Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699-5708 (2002). (Pubitemid 34556153)
76. Pflanz, S. et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172, 2225-2231 (2004). (Pubitemid 38182370)
77. Ihle, J.N. The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv. Immunol. 60, 1-35 (1995).
78. O'Shea, J.J., Gadina, M. & Schreiber, R.D. Cytokine signaling in 2002:: new surprises in the Jak/Stat pathway. Cell 109 (suppl.), S121-S131 (2002). (Pubitemid 34457857)
79. Thierfelder, W.E. et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174 (1996). (Pubitemid 26242884)
80. + T cells through Stat1-dependent and-independent mechanisms. Proc. Natl. Acad. Sci. USA 100, 15047-15052 (2003). (Pubitemid 37518014)
81. Hibbert, L., Pflanz, S., de Waal, M.R. & Kastelein, R.A. IL-27 and IFN-α signal via Stat1 and Stat3 and induce T-bet and IL-12Rβ2 in naive T cells. J. Interferon Cytokine Res. 23, 513-522 (2003). (Pubitemid 37130074)
82. O'Shea, J.J. & Paul, W.E. Regulation of TH1 differentiation- controlling the controllers. Nat. Immunol. 3, 506-508 (2002).
83. Hunter, C.A. New IL-12-family members:: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5, 521-531 (2005). (Pubitemid 40961330)
84. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006).
85. Murphy, C.A. et al. Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951-1957 (2003). (Pubitemid 38032126)
86. Batten, M. et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J. Exp. Med. 207, 2895-2906 (2010).
87. Molle, C., Goldman, M. & Goriely, S. Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process. J. Immunol. 184, 1784-1792 (2010).
88. Molle, C. et al. IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. J. Immunol. 178, 7607-7615 (2007). (Pubitemid 46898030)
89. Bauquet, A.T. et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10, 167-175 (2009).
90. Bettini, M., Castellaw, A.H., Lennon, G.P., Burton, A.R. & Vignali, D.A. Prevention of Autoimmune Diabetes by Ectopic Pancreatic beta-Cell Expression of Interleukin-35. Diabetes 61, 1519-1526 (2009).
91. Seyerl, M. et al. Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur. J. Immunol. 40, 321-329 (2010).
92. Whitehead, G.S. et al. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J. Allergy Clin. Immunol. 129, 207-215 (2012).
93. + T cells from peripheral blood of chronic hepatitis B patients. Clin. Immunol. 139, 1-5 (2011).
94. Wirtz, S., Billmeier, U., Mchedlidze, T., Blumberg, R.S. & Neurath, M.F. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 141, 1875-1886 (2011).
95. + regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J. Immunol. 184, 7144-7153 (2010).
96. Huang, C.H. et al. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J. Immunol. 187, 462-471 (2011).
97. Kuo, J., Nardelli, D.T., Warner, T.F., Callister, S.M. & Schell, R.F. Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and-infected mice. Clin. Vaccine Immunol. 18, 1125-1132 (2011).